{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:17:35Z","timestamp":1789777055099,"version":"4.0.1"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Obsessive-compulsive disorder (OCD) is characterized by recurrent distressing thoughts and repetitive behaviors, or mental rituals performed to reduce anxiety. Recent neurobiological techniques have been particularly convincing in suggesting that cortico-striatal-thalamic-cortico (CSTC) circuits, including orbitofrontal cortex (OFC) and striatum regions (caudate nucleus and putamen), are responsible for mediation of OCD symptoms. However, it is still unclear how these regions are affected by OCD treatments in adult patients. To address this yet open question, we conducted a systematic review of all studies examining neurobiological changes before and after first-line psychological OCD treatment, i.e., cognitive-behavioral therapy (CBT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Studies were included if they were conducted in adults with OCD and they assessed the neurobiological effects of CBT before and after treatment. Two databases were searched: PsycINFO and PubMed for the time frame up to May 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We obtained 26 pre-post CBT treatment studies performed using different neurobiological techniques, namely functional magnetic resonance imaging (fMRI), Positron emission tomography (PET), regional cerebral blood flow (rCBF), 5-HT concentration, magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), Electroencephalography (EEG). Neurobiological data show the following after CBT intervention: (i) reduced activations in OFC across fMRI, EEG, and rCBF; (ii) decreased activity in striatum regions across fMRI, rCBF, PET, and MRI; (iii) increased activations in cerebellum (CER) across fMRI and MRI; (iv) enhanced neurochemical concentrations in MRS studies in OFC, anterior cingulate cortex (ACC) and striatum regions. Most of these neurobiological changes are also accompanied by an improvement in symptom severity as assessed by a reduction in the Y-BOCS scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cognitive-behavioral therapy seems to be able to restructure, modify, and transform the neurobiological component of OCD, in addition to the clinical symptoms. Nevertheless, further studies are necessary to frame the OCD spectrum in a dimensional way.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2022.1063116","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T23:43:10Z","timestamp":1670542990000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Neurobiological outcomes of cognitive behavioral therapy for obsessive-compulsive disorder: A systematic review"],"prefix":"10.3389","volume":"13","author":[{"given":"Andrea","family":"Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Conversano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ciacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Loren","family":"Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo Lucherini","family":"Angeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"B1","year":"2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5."},{"key":"B2","first-page":"5","article-title":"The epidemiology and differential diagnosis of obsessive compulsive disorder.","volume":"55","author":"Rasmussen","year":"1994","journal-title":"J Clin Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","year":"2000","journal-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR).","DOI":"10.1176\/appi.books.9780890423349.15861"},{"key":"B4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/s0193-953x(05)70181-7","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder.","volume":"23","author":"Saxena","year":"2000","journal-title":"Psychiatr Clin North Am."},{"key":"B5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.conb.2011.04.010","article-title":"Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics.","volume":"21","author":"Ting","year":"2011","journal-title":"Curr Opin Neurobiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biopsych.2015.04.020","article-title":"Learning from animal models of obsessive-compulsive disorder.","volume":"79","author":"Monteiro","year":"2016","journal-title":"Biol Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","article-title":"Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways.","volume":"16","author":"Milad","year":"2012","journal-title":"Trends Cogn Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/s0925-4927(97)00016-4","article-title":"1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum.","volume":"74","author":"Ebert","year":"1997","journal-title":"Psychiatry Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.neuroimage.2004.08.041","article-title":"Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study.","volume":"24","author":"Maltby","year":"2005","journal-title":"Neuroimage."},{"key":"B10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neubiorev.2018.01.016","article-title":"Frontoparietal areas link impairments of large-scale intrinsic brain networks with aberrant fronto-striatal interactions in OCD: a meta-analysis of resting-state functional connectivity.","volume":"87","author":"G\u00fcrsel","year":"2018","journal-title":"Neurosci Biobehav Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1176\/ps.50.3.412","article-title":"Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program.","volume":"50","author":"Bystritsky","year":"1999","journal-title":"Psychiatr Serv."},{"key":"B12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000070785","article-title":"Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial.","volume":"72","author":"Volpato Cordioli","year":"2003","journal-title":"Psychother Psychosom."},{"key":"B13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.comppsych.2005.04.002","article-title":"Quality of life in obsessive-compulsive disorder before and after treatment.","volume":"46","author":"Moritz","year":"2005","journal-title":"Compr Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.psychres.2017.09.056","article-title":"Drop-out and efficacy of group versus individual cognitive behavioural therapy: what works best for obsessive-compulsive disorder? A systematic review and meta-analysis of direct comparisons.","volume":"258","author":"Pozza","year":"2017","journal-title":"Psychiatry Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/16506073.2013.773061","article-title":"Advances in the cognitive behavioural treatment of obsessive compulsive disorder.","volume":"42","author":"Shafran","year":"2013","journal-title":"Cogn Behav Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.psychres.2014.11.058","article-title":"Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder.","volume":"225","author":"McKay","year":"2015","journal-title":"Psychiatry Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cpr.2015.06.003","article-title":"Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014.","volume":"40","author":"\u00d6st","year":"2015","journal-title":"Clin Psychol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/00004714-200110000-00006","article-title":"Clinical predictors of drug response in obsessive-compulsive disorder.","volume":"21","author":"Erzegovesi","year":"2001","journal-title":"J Clin Psychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0893-133X(00)00178-0","article-title":"Low versus standard dose mCPP challenge in obsessive-compulsive patients.","volume":"24","author":"Erzegovesi","year":"2001","journal-title":"Neuropsychopharmacology."},{"key":"B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/S0007125000297857","article-title":"Role of serotonin in obsessive compulsive disorder","volume":"35","author":"Baumgarten","year":"1998","journal-title":"Br J Psychiatry Suppl."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/97811188902332017","author":"Abramowitz","year":"2017","journal-title":"The Wiley Handbook of Obsessive Compulsive Disorders."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamapsychiatry.2013.1932","article-title":"Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.","volume":"70","author":"Simpson","year":"2013","journal-title":"JAMA Psychiatry."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/14656566.2020.1775814","article-title":"What is the impact of pharmacotherapy on psychotherapy for obsessive-compulsive disorder?","volume":"21","author":"Marazziti","year":"2020","journal-title":"Expert Opin Pharmacother."},{"key":"B24","first-page":"72","article-title":"Do dysfunctional beliefs moderate the negative influence of comorbid severe depression on outcome of residential treatment for refractory OCD? A pilot study.","volume":"10","author":"Pozza","year":"2013","journal-title":"Clin Neuropsychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychires.2012.08.020","article-title":"Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators.","volume":"47","author":"Olatunji","year":"2013","journal-title":"J Psychiatr Res."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/da.22728","article-title":"Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials.","volume":"35","author":"Carpenter","year":"2018","journal-title":"Depress Anxiety."},{"key":"B29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hup.2541","article-title":"International prescribing practices in obsessive-compulsive disorder (OCD).","volume":"31","author":"Brakoulias","year":"2016","journal-title":"Hum Psychopharmacol."},{"key":"B30","year":"2022","journal-title":"Covidence Systematic Review Software."},{"key":"B31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1037\/a0018260","article-title":"Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the dimensional obsessive-compulsive scale.","volume":"22","author":"Abramowitz","year":"2010","journal-title":"Psychol Assess."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2015.01798","article-title":"From thought to action: how the interplay between neuroscience and phenomenology changed our understanding of obsessive-compulsive disorder.","volume":"6","author":"Barahona-Corr\u00eaa","year":"2015","journal-title":"Front Psychol."},{"key":"B33","year":"2014","journal-title":"Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies."},{"key":"B34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic.","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)."},{"key":"B35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jad.2015.07.048","article-title":"Regional homogeneity of spontaneous brain activity in adult patients with obsessive-compulsive disorder before and after cognitive behavioural therapy.","volume":"188","author":"Yang","year":"2015","journal-title":"J Affect Disord."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.192","article-title":"Mechanisms of cognitive-behavioral therapy for obsessive-compulsive disorder involve robust and extensive increases in brain network connectivity.","volume":"7","author":"Moody","year":"2017","journal-title":"Transl Psychiatry."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1073\/pnas.1716686115","article-title":"Multivariate resting-state functional connectivity predicts response to cognitive behavioral therapy in obsessive-compulsive disorder.","volume":"115","author":"Reggente","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.963","article-title":"The effects of cognitive behavioral therapy on resting-state functional brain network in drug-naive patients with obsessive-compulsive disorder.","volume":"8","author":"Li","year":"2018","journal-title":"Brain Behav."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s11682-020-00358-8","article-title":"FMRI hemodynamic response function (HRF) as aelker of brain function: applications for understanding obsessive-compulsive disorder pathology and treatment response.","volume":"15","author":"Rangaprakash","year":"2021","journal-title":"Brain Imaging Behav."},{"key":"B40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.biopsych.2004.12.039","article-title":"Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study.","volume":"57","author":"Nakao","year":"2005","journal-title":"Biol Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.pscychresns.2007.11.001","article-title":"Functional MRI study of brain activation alterations in patients with obsessive-compulsive disorder after symptom improvement.","volume":"163","author":"Nabeyama","year":"2008","journal-title":"Psychiatry Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1017\/S0033291710000309","article-title":"Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy.","volume":"41","author":"Freyer","year":"2011","journal-title":"Psychol Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jocrd.2013.04.006","article-title":"Neural correlates of symptom reduction after CBT in obsessive-compulsive washers\u2014an fMRI symptom provocation study.","volume":"2","author":"Baioui","year":"2013","journal-title":"J Obs Compuls Relat Disord."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071863","article-title":"Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reports.","volume":"8","author":"Schiepek","year":"2013","journal-title":"PLoS One."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1017\/S0033291713002237","article-title":"Dynamics of psychotherapy-related cerebral haemodynamic changes in obsessive compulsive disorder using a personalized exposure task in functional magnetic resonance imaging.","volume":"44","author":"Morgi\u00e8ve","year":"2014","journal-title":"Psychol Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1590\/1516-4446-2017-2449","article-title":"Pituitary gland volumes in patients with obsessive-compulsive disorder before and after cognitive-behavioral therapy.","volume":"40","author":"Atmaca","year":"2018","journal-title":"Braz J Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1201","article-title":"Abnormalities of white matter microstructure in unmedicated patients with obsessive-compulsive disorder: changes after cognitive behavioral therapy.","volume":"9","author":"Zhong","year":"2019","journal-title":"Brain Behav."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110037","article-title":"The effects of cognitive behavioral therapy on the whole brain structural connectome in unmedicated patients with obsessive-compulsive disorder.","volume":"104","author":"Cao","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B49","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/archpsyc.1992.01820090009002","article-title":"Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.","volume":"49","author":"Baxter","year":"1992","journal-title":"Arch Gen Psychiatry."},{"key":"B50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/archpsyc.1996.01830020023004","article-title":"Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.","volume":"53","author":"Schwartz","year":"1996","journal-title":"Arch Gen Psychiatry."},{"key":"B51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pscychresns.2010.08.012","article-title":"Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.","volume":"184","author":"Apostolova","year":"2010","journal-title":"Psychiatry Res."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0128-4","article-title":"Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.","volume":"8","author":"Lissemore","year":"2018","journal-title":"Transl Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.mp.4002134","article-title":"Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder.","volume":"14","author":"Saxena","year":"2009","journal-title":"Mol Psychiatry."},{"key":"B54","doi-asserted-by":"crossref","first-page":"p. 587","DOI":"10.1093\/oso\/9780198566960.003.0027","article-title":"The role of cingulate cortex dysfunction in obsessive\u2013compulsive disorder.","author":"Saxena","year":"2009","journal-title":"Cingulate Neurobiology and Disease."},{"key":"B55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0925-4927(03)00069-6","article-title":"Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder.","volume":"124","author":"Nakatani","year":"2003","journal-title":"Psychiatry Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.pscychresns.2008.07.004","article-title":"Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder.","volume":"172","author":"Yamanishi","year":"2009","journal-title":"Psychiatry Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1590\/1516-4446-2015-1721","article-title":"The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder.","volume":"38","author":"Sampaio","year":"2016","journal-title":"Braz J Psychiatry."},{"key":"B58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pscychresns.2011.04.004","article-title":"The effect of behavior therapy on caudate N-acetyl-l-aspartic acid in adults with obsessive-compulsive disorder.","volume":"201","author":"Whiteside","year":"2012","journal-title":"Psychiatry Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jpsychires.2012.11.010","article-title":"Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.","volume":"47","author":"O\u2019Neill","year":"2013","journal-title":"J Psychiatr Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0925-4927(02)00104-x","article-title":"Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.","volume":"122","author":"Kwon","year":"2003","journal-title":"Psychiatry Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/13651501.2015.1072220","article-title":"1HMRS results of hippocampus in the patients with obsessive-compulsive disorder before and after cognitive behavioral therapy.","volume":"19","author":"Atmaca","year":"2015","journal-title":"Int J Psychiatry Clin Pract."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.jpsychires.2013.09.003","article-title":"P300 in obsessive-compulsive disorder: source localization and the effects of treatment.","volume":"47","author":"Andreou","year":"2013","journal-title":"J Psychiatr Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1017\/S0033291713002237","article-title":"Dynamics of psychotherapy-related cerebral haemodynamic changes in obsessive compulsive disorder using a personalized exposure task in functional magnetic resonance imaging","volume":"44","author":"Morgi\u00e9ve","year":"2014","journal-title":"Psychol Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291720005437","article-title":"Towards a definitive symptom structure of obsessive- compulsive disorder: a factor and network analysis of 87 distinct symptoms in 1366 individuals.","author":"Cervin","year":"2021","journal-title":"Psychol Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jpsychires.2015.05.001","article-title":"Obsessive-compulsive disorder\u2013a question of conscience? An fMRI study of behavioural and neurofunctional correlates of shame and guilt.","volume":"68","author":"Hennig-Fast","year":"2015","journal-title":"J Psychiatr Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archpsyc.61.6.564","article-title":"Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder.","volume":"61","author":"Mataix-Cols","year":"2004","journal-title":"Arch Gen Psychiatry."},{"key":"B67","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/brain\/awn267","article-title":"The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems.","author":"van den Heuvel","year":"2009","journal-title":"Brain."},{"key":"B68","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s40501-018-0142-4","article-title":"Symptom dimensions in obsessive-compulsive disorder as predictors of neurobiology and treatment response.","volume":"5","author":"Thorsen","year":"2018","journal-title":"Curr Treat Options Psychiatry."},{"key":"B69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2005.10.005","article-title":"Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.","volume":"150","author":"Ma","year":"2007","journal-title":"Psychiatry Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1017\/S1092852900002479","article-title":"Neurobiology of obsessive-compulsive disorder: serotonin and beyond.","volume":"12","author":"Westenberg","year":"2007","journal-title":"CNS Spectr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.drudis.2007.12.009","article-title":"Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder.","volume":"13","author":"Goddard","year":"2008","journal-title":"Drug Discov Today."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001765.pub3","article-title":"Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).","volume":"2008","author":"Soomro","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0306-4530(00)00048-2","article-title":"Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder.","volume":"26","author":"Khanna","year":"2001","journal-title":"Psychoneuroendocrinology."},{"key":"B74","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/S1461145705005055","article-title":"Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.","volume":"8","author":"Adams","year":"2005","journal-title":"Int J Neuropsychopharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D dopamine dysfunction in drug-naive obsessive-compulsive disorder.","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage."},{"key":"B76","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.biopsych.2011.06.023","article-title":"Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.","volume":"70","author":"Simpson","year":"2011","journal-title":"Biol Psychiatry."},{"key":"B77","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.npp.1301199","article-title":"Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-na\u00efve patients.","volume":"32","author":"Moresco","year":"2007","journal-title":"Neuropsychopharmacology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"p. 463","DOI":"10.1093\/med\/9780190228163.003.0041","article-title":"The pharmacological treatment of refractory OCD.","author":"Pittenger","year":"2017","journal-title":"Obsessive-compulsive Disorder: Phenomenology, Pathophysiology, and Treatment."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.83","article-title":"Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians. Pharmacogenomics. 2014;15(8):1147-57.","volume":"16","author":"Zai","year":"2015","journal-title":"Erratum Pharmacogenomics."},{"key":"B80","first-page":"43","article-title":"The tic-related obsessive-compulsive disorder phenotype and treatment implications.","volume":"85","author":"Miguel","year":"2001","journal-title":"Adv Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in tourette syndrome and obsessive-compulsive disorder.","volume":"23","author":"Denys","year":"2013","journal-title":"Eur Neuropsychopharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.294.5544.980","article-title":"\u2018Behavioral\u2019 addictions: do they exist?","volume":"294","author":"Holden","year":"2001","journal-title":"Science."},{"key":"B83","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tins.2009.06.004","article-title":"Roles for nigrostriatal\u2013not just mesocorticolimbic\u2013dopamine in reward and addiction.","volume":"32","author":"Wise","year":"2009","journal-title":"Trends Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1017\/S146114571200154X","article-title":"Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.","volume":"16","author":"Sesia","year":"2013","journal-title":"Int J Neuropsychopharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0278-5846(03)00039-3","article-title":"Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases.","volume":"27","author":"Lykouras","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B86","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/YCO.0000000000000017","article-title":"Obsessive compulsive disorder and the glutamatergic system.","volume":"27","author":"Kariuki-Nyuthe","year":"2014","journal-title":"Curr Opin Psychiatry."},{"key":"B87","first-page":"205","article-title":"Glutamate genetics in obsessive-compulsive disorder: a review.","volume":"26","author":"Rajendram","year":"2017","journal-title":"J Can Acad Child Adolesc Psychiatry."},{"key":"B88","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1523\/JNEUROSCI.1906-17.2017","article-title":"Neuronal glutamate transporters control dopaminergic signaling and compulsive behaviors.","volume":"38","author":"Bellini","year":"2018","journal-title":"J Neurosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/1875397300802010062","article-title":"Glutamatergic synaptic dysfunction and obsessive-compulsive disorder.","volume":"2","author":"Ting","year":"2008","journal-title":"Curr Chem Genomics."},{"key":"B90","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2015.02.009","article-title":"Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies.","volume":"52","author":"Naaijen","year":"2015","journal-title":"Neurosci Biobehav Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/npp.2016.260","article-title":"Fronto-striatal glutamate in autism spectrum disorder and obsessive compulsive disorder. Neuropsychopharmacology. 2017;42(12):2456-2465.","volume":"42","author":"Naaijen","year":"2017","journal-title":"Erratum Neuropsychopharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00702-008-0045-4","article-title":"A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.","volume":"115","author":"Starck","year":"2008","journal-title":"J Neural Transm (Vienna)."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B94","doi-asserted-by":"publisher","first-page":"p. 271","DOI":"10.1093\/med\/9780190228163.003.0025","article-title":"Neurotransmitter dysregulation in OCD","author":"Graat","year":"2017","journal-title":"Christopher P editor. Obsessive-Compulsive Disorder: phenomenology, Pathophysiology, and Treatment"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/npp.2012.132","article-title":"Investigation of cortical glutamate-glutamine and \u03b3-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.","volume":"37","author":"Simpson","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pscychresns.2015.06.001","article-title":"In vivo effects of ketamine on glutamate-glutamine and \u03b3-aminobutyric acid in obsessive-compulsive disorder: proof of concept.","volume":"233","author":"Rodriguez","year":"2015","journal-title":"Psychiatry Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/npp.2011.300","article-title":"Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder.","volume":"37","author":"Richter","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2160-1","article-title":"Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.","volume":"19","author":"Li","year":"2019","journal-title":"BMC Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1063116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T13:19:49Z","timestamp":1701523189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1063116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":98,"alternative-id":["10.3389\/fpsyt.2022.1063116"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.1063116","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"article-number":"1063116"}}